ArticleMolecular therapy. Oncology2024

Development of a novel, high-efficacy oncolytic herpes simplex virus type 1 platform equipped with two distinct retargeting modalities.

Hyun-Yoo Joo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.